vigabatrin
Drug Details
- Generic Name
- vigabatrin
- Brand Names
- vigabatrin for oral solution, vigabatrin, Vigabatrin, VIGAFYDE, VIGADRONE, SABRIL, VIGABATRIN
- Application Number
- ANDA213519
- Sponsor
- Camber Pharmaceuticals, Inc.
- NDC Codes
- 14
- Dosage Forms
- POWDER, FOR SOLUTION, TABLET, FILM COATED, FOR SOLUTION, SOLUTION
- Routes
- ORAL
- Active Ingredients
- VIGABATRIN
Indications and Usage
1. INDICATIONS AND USAGE Vigabatrin for oral solution is indicated for the treatment of: Refractory Complex Partial Seizures as adjunctive therapy in patients 2 years of age and older who have responded inadequately to several alternative treatments; vigabatrin for oral solution is not indicated as a first line agent ( 1.1 ) Infantile Spasms -monotherapy in infants 1 month to 2 years of age for whom the potential benefits outweigh the potential risk of vision loss ( 1.2 ) 1.1 Refractory Complex Partial Seizures (CPS) Vigabatrin for oral solution is indicated as adjunctive therapy for adults and pediatric patients 2 years of age and older with refractory complex partial seizures who have inadequately responded to several alternative treatments and for whom the potential benefits outweigh the risk of vision loss [see Warnings and Precautions ( 5.1 )]. Vigabatrin for oral solution is not indicated as a first line agent for complex partial seizures. 1.2 Infantile Spasms (IS) Vigabatrin for oral solution is indicated as monotherapy for pediatric patients with infantile spasms 1 month to 2 years of age for whom the potential benefits outweigh the potential risk of vision loss [see Warnings and Precautions ( 5.1 )].